Complete Filing Data
Unusual Machines, Inc. reported Stockholders Equity of $174.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Unusual Machines, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | -$19.2M | -$32.0M | -$2.4M | -$1.2M |
| Revenues | $11.2M | $5.6M | $0.00 | $0.00 |
| Research And Development Expense | $202.6K | $90.6K | $0.00 | $91.3K |
| Operating Income Loss | -$25.2M | -$17.0M | -$2.4M | -$1.2M |
| Operating Expenses | $29.1M | $18.5M | $2.4M | $1.2M |
| Nonoperating Income Expense | $5.9M | -$15.0M | $0.00 | $148.00 |
| Gross Profit | $3.9M | $1.5M | $0.00 | $0.00 |
| General And Administrative Expense | $23.9M | $6.3M | $2.4M | $1.2M |
| Selling And Marketing Expense | $1.6M | $1.1M | $0.00 | |
| Interest Expense Nonoperating | $519.00 | $117.0K | $0.00 | |
| Deferred Revenue Current | $638.1K | $197.1K | $0.00 | |
| Income Tax Expense Benefit | -$36.3K | -$13.4K | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$19.2M | -$32.0M | -$2.4M | -$1.2M |
| Cost Of Revenue | $7.3M | $4.0M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $1.6M | -$7.0M | -$3.3M | -$2.1M | -$1.6M | -$1.1M | -$353.7K | -$435.3K | -$1.2M |
| Revenues | $2.1M | $2.1M | $2.0M | $1.5M | $1.4M | $618.9K | $0.00 | $0.00 | $0.00 |
| Research And Development Expense | $39.4K | $62.7K | $7.9K | $15.0K | $10.3K | $16.8K | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$5.0M | -$7.2M | -$3.3M | -$1.5M | -$1.6M | -$1.1M | -$353.7K | -$435.3K | -$588.9K |
| Operating Expenses | $5.8M | $8.0M | $3.8M | $1.9M | $2.0M | $1.3M | $353.7K | $435.3K | $588.9K |
| Nonoperating Income Expense | $6.6M | $225.7K | $1.5K | -$683.2K | -$40.5K | -$19.6K | $0.00 | $0.00 | $0.00 |
| Gross Profit | $840.4K | $794.7K | $496.8K | $399.5K | $388.4K | $204.2K | $0.00 | $0.00 | $0.00 |
| General And Administrative Expense | $4.7M | $7.2M | $3.2M | $1.4M | $1.3M | $1.0M | $353.0K | $434.9K | $588.5K |
| Selling And Marketing Expense | $373.5K | $302.4K | $207.6K | $252.3K | $386.3K | $157.1K | $0.00 | $0.00 | $0.00 |
| Interest Expense Nonoperating | $0.00 | $0.00 | $0.00 | $41.5K | $40.5K | $19.6K | $0.00 | $0.00 | |
| Deferred Revenue Current | $1.5M | $139.4K | $117.2K | $300.5K | $82.1K | $176.3K | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.3M | -$1.1M | -$588.9K | ||||||
| Cost Of Revenue | $1.3M | $1.3M | $1.5M | $1.1M | $1.0M | $414.7K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $174.9M | $14.8M | $1.4M | $3.2M | $3.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $103.3M | $3.8M | $894.8K | $3.1M | $3.8M |
| Retained Earnings Accumulated Deficit | -$55.1M | -$35.9M | -$3.9M | -$1.5M | |
| Property Plant And Equipment Net | $2.2M | $570.00 | $1.3K | $3.7K | |
| Other Assets Current | $190.6K | $31.5K | $120.6K | $139.4K | |
| Liabilities Current | $2.6M | $933.7K | $114.5K | $120.9K | |
| Liabilities And Stockholders Equity | $182.7M | $16.1M | $1.5M | $3.3M | |
| Common Stock Value | $377.6K | $151.2K | $32.2K | $33.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $99.5M | $2.9M | -$2.2M | -$686.5K | |
| Cash And Cash Equivalents At Carrying Value | $103.3M | $3.8M | $894.8K | $3.1M | |
| Assets Noncurrent | $23.2M | $10.0M | $514.0K | $3.7K | |
| Assets Current | $159.5M | $6.1M | $1.0M | $3.3M | |
| Assets | $182.7M | $16.1M | $1.5M | $3.3M | |
| Accounts Payable And Other Accrued Liabilities Current | $1.5M | $668.7K | $114.5K | $120.9K | |
| Operating Lease Right Of Use Asset | $2.6M | $323.5K | $0.00 | ||
| Operating Lease Liability Noncurrent | $2.2M | $262.2K | $0.00 | ||
| Operating Lease Liability Current | $456.4K | $67.8K | $0.00 | ||
| Noncash Consideration Paid For Assets Acquired And Liabilities Assumed | $8.8M | $21.0M | $0.00 | ||
| Liabilities | $7.8M | $1.3M | $114.5K | ||
| Inventory Net | $5.3M | $1.3M | $0.00 | ||
| Deferred Offering Costs | $0.00 | $512.8K | $87.8K | ||
| Deferred Offering Costs Recorded As Reduction Of Proceeds | $0.00 | $512.8K | $0.00 | ||
| Deferred Acquisition Costs | $100.0K | $0.00 | |||
| Accounts Receivable Net Current | $1.6M | $66.6K | $0.00 | ||
| Preferred Stock Value | $1.00 | ||||
| Intangible Assets Net Including Goodwill | |||||
| Prepaid Inventory | |||||
| Notes Payable | |||||
| Goodwill | $15.6M | $7.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $106.0M | $51.3M | $15.9M | $19.2M | $20.0M | $21.2M | $1.8M | $2.2M | $2.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $64.3M | $38.9M | $5.0M | $1.7M | $2.2M | $3.2M | $1.3M | $1.9M | $2.6M | |
| Retained Earnings Accumulated Deficit | -$44.5M | -$46.1M | -$39.2M | -$8.8M | -$6.7M | -$4.4M | ||||
| Property Plant And Equipment Net | $1.7M | $263.0K | $399.00 | $741.00 | $912.00 | $1.1K | ||||
| Other Assets Current | $218.9K | $192.8K | $205.1K | $158.1K | $182.1K | $278.3K | ||||
| Liabilities Current | $5.9M | $821.7K | $1.0M | $2.0M | $931.2K | $692.0K | ||||
| Liabilities And Stockholders Equity | $113.1M | $52.4M | $17.3M | $24.5M | $25.2M | $24.2M | ||||
| Common Stock Value | $315.7K | $252.9K | $168.3K | $61.9K | $104.1K | $93.3K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.2M | $2.3M | -$542.4K | |||||||
| Cash And Cash Equivalents At Carrying Value | $64.3M | $38.9M | $5.0M | $1.7M | $2.2M | $3.2M | ||||
| Assets Noncurrent | $21.4M | $10.2M | $10.0M | $20.0M | $20.1M | $18.1M | ||||
| Assets Current | $91.7M | $42.2M | $7.3M | $4.5M | $5.1M | $6.1M | ||||
| Assets | $113.1M | $52.4M | $17.3M | $24.5M | $25.2M | $24.2M | ||||
| Accounts Payable And Other Accrued Liabilities Current | $1.2M | $608.7K | $860.6K | $1.0M | $786.6K | $455.8K | ||||
| Operating Lease Right Of Use Asset | $1.3M | $288.5K | $306.3K | $340.4K | $357.0K | $373.1K | ||||
| Operating Lease Liability Noncurrent | $1.0M | $223.8K | $243.2K | $280.3K | $297.3K | $313.9K | ||||
| Operating Lease Liability Current | $248.0K | $73.6K | $70.7K | $65.1K | $62.5K | $59.9K | ||||
| Noncash Consideration Paid For Assets Acquired And Liabilities Assumed | $0.00 | $19.0M | $0.00 | |||||||
| Liabilities | $7.1M | $1.1M | $1.4M | $5.3M | $5.2M | $3.0M | ||||
| Inventory Net | $3.1M | $1.6M | $1.2M | $1.5M | $1.6M | $1.6M | ||||
| Deferred Offering Costs | $0.00 | $0.00 | $0.00 | |||||||
| Deferred Offering Costs Recorded As Reduction Of Proceeds | $0.00 | $512.8K | ||||||||
| Deferred Acquisition Costs | $0.00 | $100.0K | $0.00 | |||||||
| Accounts Receivable Net Current | $309.5K | $173.4K | $51.0K | $79.9K | $1.9K | |||||
| Preferred Stock Value | $1.00 | $1.00 | $2.00 | |||||||
| Intangible Assets Net Including Goodwill | $19.7M | $19.7M | $17.7M | $0.00 | ||||||
| Prepaid Inventory | $1.1M | $1.1M | $0.00 | |||||||
| Notes Payable | $3.0M | $4.0M | $0.00 | |||||||
| Goodwill | $7.4M | $7.4M | $7.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$21.2M | -$4.0M | -$1.8M | -$1.2M |
| Net Cash Provided By Used In Investing Activities | -$37.1M | -$852.8K | -$3.2K | -$4.6K |
| Increase Decrease In Other Current Assets | $137.3K | -$54.9K | -$18.7K | $24.2K |
| Increase Decrease In Accounts Receivable | $1.6M | $59.8K | $0.00 | -$945.00 |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $745.9K | $266.7K | -$17.4K | $120.9K |
| Payments To Acquire Businesses Net Of Cash Acquired | -$93.1K | $852.8K | $0.00 | |
| Increase Decrease In Prepaid Expense | $8.8M | $83.7K | $0.00 | |
| Increase Decrease In Operating Lease Liability | $2.2M | -$48.4K | $0.00 | |
| Increase Decrease In Inventories | $3.9M | -$455.1K | $0.00 | |
| Share Based Compensation | $15.6M | $2.3M | $600.0K | |
| Increase Decrease In Other Current Liabilities | $257.3K | $82.7K | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $2.1M | $0.00 | $3.2K | $4.6K |
| Net Cash Provided By Used In Financing Activities | $157.8M | $7.7M | -$424.9K | $549.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.2M | -$1.2M | -$542.4K |
| Net Cash Provided By Used In Investing Activities | $0.00 | -$852.9K | $0.00 |
| Increase Decrease In Other Current Assets | $156.4K | $41.6K | -$11.3K |
| Increase Decrease In Accounts Receivable | -$15.6K | -$4.9K | $0.00 |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $191.8K | $53.7K | $105.1K |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $852.9K | $0.00 |
| Increase Decrease In Prepaid Expense | -$69.4K | $377.1K | $0.00 |
| Increase Decrease In Operating Lease Liability | -$16.1K | -$4.6K | $0.00 |
| Increase Decrease In Inventories | -$121.2K | -$148.8K | $0.00 |
| Share Based Compensation | $1.9M | $64.3K | $0.00 |
| Increase Decrease In Other Current Liabilities | -$79.9K | $61.8K | |
| Payments To Acquire Property Plant And Equipment | |||
| Net Cash Provided By Used In Financing Activities | $2.4M | $4.4M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 26.0M | 8.3M | 3.3M | 4.0M |
| Earnings Per Share Diluted | $-0.74 | $-3.84 | $-0.72 | $-0.31 |
| Earnings Per Share Basic | $-0.74 | $-3.84 | $-0.72 | |
| Common Stock Shares Outstanding | 37.8M | 15.1M | 3.2M | 3.4M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Issued | 37.8M | 15.1M | 3.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 30.6M | 21.8M | 15.9M | 7.1M | 10.0M | 6.1M | 3.2M | 3.4M | 3.4M |
| Earnings Per Share Diluted | $0.05 | $-0.32 | $-0.21 | $-0.30 | $-0.16 | $-0.18 | $-0.11 | $-0.13 | $-0.17 |
| Earnings Per Share Basic | $0.05 | $-0.32 | $-0.21 | $-0.30 | $-0.16 | $-0.18 | $-0.11 | $-0.13 | $-0.17 |
| Common Stock Shares Outstanding | 31.6M | 25.3M | 16.8M | 6.2M | 10.4M | 9.3M | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Common Stock Shares Issued | 31.6M | 25.3M | 16.8M | 6.2M | 10.4M | 9.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Interest And Other Income | $1.8M | $1.1K | $0.00 | $148.00 |
| Additional Paid In Capital | $229.7M | $50.6M | $5.3M | $4.7M |
| Stock Compensation Expense As Settlement | $0.00 | $64.3K | $0.00 | |
| Derivative Gain Loss On Derivative Net | $0.00 | -$16.1M | $0.00 | |
| Other Cost And Expense Operating | $3.2M | $959.7K | $0.00 | |
| Stock Granted During Period Value Sharebased Compensation | $13.8M | $2.2M | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.9M | $60.9K | ||
| Stock Issued During Period Value Acquisitions | $17.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Interest And Other Income | $715.5K | $225.7K | $1.5K | $180.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid In Capital | $150.2M | $97.2M | $54.9M | $28.0M | $26.5M | $25.6M | |
| Stock Compensation Expense As Settlement | |||||||
| Derivative Gain Loss On Derivative Net | $0.00 | $43.2K | $0.00 | ||||
| Other Cost And Expense Operating | $636.7K | $404.3K | $302.6K | $218.1K | $213.8K | $112.3K | |
| Stock Granted During Period Value Sharebased Compensation | $1.9M | $375.3K | $346.9K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $22.9K | $23.1K | $14.4K | ||||
| Stock Issued During Period Value Acquisitions | $17.0M |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.